Your browser doesn't support javascript.
loading
Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study.
Sternberg, Cora N; Castellano, Daniel; de Bono, Johann; Fizazi, Karim; Tombal, Bertrand; Wülfing, Christian; Kramer, Gero; Eymard, Jean-Christophe; Bamias, Aristotelis; Carles, Joan; Iacovelli, Roberto; Melichar, Bohuslav; Sverrisdóttir, Ásgerður; Theodore, Christine; Feyerabend, Susan; Helissey, Carole; Poole, Elizabeth M; Ozatilgan, Ayse; Geffriaud-Ricouard, Christine; de Wit, Ronald.
Afiliação
  • Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Meyer Cancer Center, New York, NY, USA. Electronic address: cns9006@med.cornell.edu.
  • Castellano D; 12 de Octubre University Hospital, Madrid, Spain.
  • de Bono J; The Institute of Cancer Research and the Royal Marsden Hospital, London, UK.
  • Fizazi K; Gustave Roussy Institute and University of Paris Saclay, Villejuif, France.
  • Tombal B; Institute de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium.
  • Wülfing C; Department of Urology, Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg, Germany.
  • Kramer G; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Eymard JC; Jean Godinot Institute, Reims, France.
  • Bamias A; Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Iacovelli R; Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy; Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy.
  • Melichar B; Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
  • Sverrisdóttir Á; Landspitali University Hospital, Reykjavik, Iceland.
  • Theodore C; Foch Hospital, Suresnes, France.
  • Feyerabend S; Studienpraxis Urologie, Nürtingen, Germany.
  • Helissey C; Hôpital D'Instruction des Armées, Bégin, Saint Mandé, France.
  • Poole EM; Sanofi, Global Medical Oncology, Cambridge, MA, USA.
  • Ozatilgan A; Sanofi, Global Medical Oncology, Cambridge, MA, USA.
  • Geffriaud-Ricouard C; Sanofi, Europe Medical Oncology, Paris, France.
  • de Wit R; Erasmus University Hospital, Rotterdam, The Netherlands.
Eur Urol ; 80(4): 497-506, 2021 10.
Article em En | MEDLINE | ID: mdl-34274136
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Taxoides / Neoplasias de Próstata Resistentes à Castração / Nitrilas Tipo de estudo: Clinical_trials Limite: Aged / Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Taxoides / Neoplasias de Próstata Resistentes à Castração / Nitrilas Tipo de estudo: Clinical_trials Limite: Aged / Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Suíça